Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Generate Biomedicines, Inc. (GENB) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$6.31M |
|
$-67.25M |
|
-- |
|
$6.31M |
|
$77.93M |
|
$-71.61M |
|
$4.41M |
|
$-67.20M |
|
$-67.20M |
|
$-67.25M |
|
$-67.25M |
|
$-67.25M |
|
$-67.25M |
|
$-71.61M |
|
$-68.78M |
|
128.24M |
|
128.24M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$470.25M |
|
$27.30M |
|
$91.44M |
|
$561.69M |
|
$56.64M |
|
$1.37M |
|
$49.01M |
|
$105.64M |
|
$456.05M |
|
$456.05M |
|
$456.05M |
|
128.27M |
|
| Cash Flow Statement Financials | |
$-138.33M |
|
$-226.62M |
|
$378.31M |
|
$126.04M |
|
$139.39M |
|
$13.36M |
|
$14.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.30 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.01 |
|
100.00% |
|
-1134.21% |
|
-1134.21% |
|
-- |
|
-1064.33% |
|
-1065.17% |
|
$-143.05M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-14.75% |
|
-14.75% |
|
-11.97% |
|
-14.70% |
|
$3.56 |
|
$-1.12 |
|
$-1.08 |
|